DNTH
Dianthus Therapeutics Inc.
Company Overview
| Mkt Cap | $1.06B | Price | $34.98 |
| Volume | 322.82K | Change | +3.68% |
| P/E Ratio | -12.5 | Open | $33.75 |
| Revenue | $6.2M | Prev Close | $33.74 |
| Net Income | $-85.0M | 52W Range | $13.37 - $40.16 |
| Div Yield | N/A | Target | $63.45 |
| Overall | 50 | Value | 60 |
| Quality | -- | Technical | 40 |
No chart data available
Stock Overview
Updated DailyDianthus Therapeutics Inc. (DNTH) is a leading diversified company in the business industry, currently trading at $34.98 with a market capitalization of $1.06 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows DNTH with a volume of 323K shares. The stock opened up 0.03% from yesterday's close of $33.74. Current analyst estimates project earnings of $-3.41 per share for this year, with next year targeting $-3.56.
DNTH demonstrates weak technical indicators based on technical analysis. The company trades on the NSC exchange.
Key investment considerations for DNTH include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 81.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 03:58 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNTH | $34.98 | +3.7% | 322.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dianthus Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW